×

Stocks Merck & Co Inc

  • merck_sign.jpg

    Earlier this week UBS pharmaceutical analyst Roopesh Patel put out a big 2009 sector outlook research note claiming, "So far, the global economic slowdown has had no noticeable impact — a) U.S. weekly and monthly U.S. prescription trends are stable; b) there also is no meaningfully cautionary commentary from any of the companies...." Well, he might have spoken too soon.

  • Stocks opened lower Thursday amid a fresh round of layoffs and dismal same-store sales numbers, but soon turned mixed after an unexpected drop in jobless claims and better-than-expected factory-orders report.

  • Sweden, Bank of England, and now the ECB have all cut interest rates, the ECB by a record 75 basis points to 2.5 percent. On the U.S. front, there is mostly negative news. Let's see how much of this negative news has been priced into the market.

  • The latest job cuts  in the banking sector come amid an overall wave of layoffs across the United States as companies move to cut costs in the face of slackening demand and a general economic downturn.

  • U.S. stock index futures were getting battered by a fresh round of layoff announcements by some major companies and mostly dismal news about retail sales.

  • Health care has been one of the best performing sectors in the S&P 500 this year. Are these stocks good for what ails you?

  • The latest job cuts  in the banking sector come amid an overall wave of layoffs across the United States as companies move to cut costs in the face of slackening demand and a general economic downturn.

  • pharma_new2.jpg

    Look for M&A activity—big and small—a pair of breakthrough drugs and the prospect of government price controls.

  • The latest job cuts  in the banking sector come amid an overall wave of layoffs across the United States as companies move to cut costs in the face of slackening demand and a general economic downturn.

  • The latest job cuts  in the banking sector come amid an overall wave of layoffs across the United States as companies move to cut costs in the face of slackening demand and a general economic downturn.

  • The latest job cuts  in the banking sector come amid an overall wave of layoffs across the United States as companies move to cut costs in the face of slackening demand and a general economic downturn.

  • The latest job cuts  in the banking sector come amid an overall wave of layoffs across the United States as companies move to cut costs in the face of slackening demand and a general economic downturn.

  • cadeuses2.jpg

    As the market remains focused on Citi and the President-elect's midday cabinet announcement there are a few newsworthy things going on in biopharmaland.

  • The latest job cuts  in the banking sector come amid an overall wave of layoffs across the United States as companies move to cut costs in the face of slackening demand and a general economic downturn.

  • The latest job cuts  in the banking sector come amid an overall wave of layoffs across the United States as companies move to cut costs in the face of slackening demand and a general economic downturn.

  • The latest job cuts  in the banking sector come amid an overall wave of layoffs across the United States as companies move to cut costs in the face of slackening demand and a general economic downturn.

  • Health-care reform is not the only thing big pharmaceuticals have to fear, according to Deutsche Bank's Barbara Ryan.  There's also the rapidly-growing dominance of generic prescription drugs.  Still, she likes several big-name companies in the field.

  • Markets are braced for more hemorrhaging in jobs, with a Friday employment report expected to record 200,00 more jobs vaporized in October. This would push the jobless rate up two-tenths of a point to 6.3 percent.

  • gardasil_logo.jpg

    How in the world is Merck gonna rebrand a product it has spent so much time, effort and money gearing toward females so that males will use it, too? I'm not sure, but it'll be interesting to watch if or when MRK wins Food and Drug Administration approval of Gardasil for boys/young men.

  • Markets are braced for more hemorrhaging in jobs, with a Friday employment report expected to record 200,00 more jobs vaporized in October. This would push the jobless rate up two-tenths of a point to 6.3 percent.